For the Quarter Ending September 2025
North America
• In United States, the Chlorpheniramine Maleate Price Index remained stable quarter-over-quarter in Q3 2025, influenced by global overcapacity.
• Chlorpheniramine Maleate production costs increased in Q3 2025, driven by a 2.6% PPI rise year-over-year in August 2025.
• Natural gas prices strengthened in September 2025, and electricity climbed in August 2025, raising manufacturing expenses.
• US tariffs in Q3 2025 pressured the chemical sector, contributing to Chlorpheniramine Maleate cost increases.
• Consumer demand for Chlorpheniramine Maleate cooled in Q3 2025, despite 5.42% retail sales growth in September 2025.
• A 3.0% CPI increase year-over-year in September 2025 indicated inflation, impacting raw material and labor costs.
• The 4.3% unemployment rate in September 2025 supported purchasing, but consumer confidence declined to 94.2.
• Global overcapacity, particularly from China, kept Chlorpheniramine Maleate chemical margins tight throughout Q3 2025.
Why did the price of Chlorpheniramine Maleate change in September 2025 in North America?
• Production costs rose due to a 2.6% PPI increase in August 2025 and higher energy prices.
• Cooling consumer demand in Q3 2025, despite strong retail sales, limited cost pass-through.
• Global overcapacity, particularly from China, pressured Chlorpheniramine Maleate prices in Q3 2025.
APAC
• In China, the Chlorpheniramine Maleate Price Index fell quarter-over-quarter in Q3 2025, driven by industrial deflationary pressures.
• Chlorpheniramine Maleate production costs remained elevated in September 2025 due to increased key raw material prices.
• Pharmaceutical demand strengthened from August to September 2025, boosting Chlorpheniramine Maleate consumption.
• China's Manufacturing Index contracted in July and August 2025, signaling reduced API orders.
• The CPI decreased by 0.3% year-on-year in September 2025, indicating weak consumer demand.
• PPI declined by 2.3% year-on-year in September 2025, reflecting falling producer prices.
• Retail sales increased by 3.0% year-on-year in September 2025, supporting end-use product demand.
• Industrial production grew 6.5% in September 2025, while consumer confidence at 89.6 dampened spending.
Why did the price of Chlorpheniramine Maleate change in September 2025 in APAC?
• Deflationary CPI of -0.3% in September 2025 indicated weak consumer demand, pressuring Chlorpheniramine Maleate prices.
• A 2.3% PPI decline in September 2025 reflected falling producer prices and overall weak industrial demand.
• Persistent global chemical overcapacity, especially from China, contributed to downward pressure on Chlorpheniramine Maleate prices.
Europe
• In Germany, the Chlorpheniramine Maleate Price Index fell quarter-over-quarter in Q3 2025, influenced by subdued demand and decreasing producer input costs.
• Production costs were pressured by elevated raw material and high energy prices throughout Q3 2025.
• Demand for Chlorpheniramine Maleate remained subdued in Q3 2025, despite a modest 0.2% increase in retail sales.
• The Manufacturing Index contracted and industrial production declined 1.0% in September 2025, signaling a weaker economic environment.
• A stable unemployment rate of 6.3% in September 2025 indicated ongoing economic challenges constraining consumer spending.
• Pharmaceutical sector production strengthened in July 2025, offering a positive signal for Chlorpheniramine Maleate demand.
• Global chemical overcapacity persisted, with low capacity utilization in German industry during Q3 2025.
• German chemical exports weakened significantly in Q3 2025, and new tariffs impacted trade with the United States.
Why did the price of Chlorpheniramine Maleate change in September 2025 in Europe?
• Producer Price Index declined 1.7% in September 2025, reducing input costs for German manufacturers.
• Industrial production fell 1.0% in September 2025, contributing to subdued overall chemical demand.
• Consumer Price Index rose 2.4% year-over-year in September 2025, impacting consumer spending.
